SK Knee System
Just Medical Devices (Tianjin) Co., Ltd. · Decision date Sep 1, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for the SK Knee System, submitted by Just Medical Devices (Tianjin) Co., Ltd., with a decision date of September 1, 2026. The device is a cemented total knee replacement system classified under 21 CFR 888.3560, product code JWH, in the orthopedic specialty. The summary describes cruciate-retaining and posterior-stabilized femoral components, tibial trays, modular UHMWPE tibial bearings and patellar bearings, with cast CoCrMo femoral and tibial components.
The submission lists K113550 Vanguard Complete Knee System as primary predicate, with K183583 and K101433 also cited; the summary states the indications match the predicate's. Stated differences include an anterior stabilized tibial insert, patellar thickness options, seven versus nine tibial sizes, and cemented-only use. The summary cites preclinical bench testing only. The public record does not include clinical outcome data, and the summary's predicate numbering is internally inconsistent, so the exact predicate set should be verified against the source PDF.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Sep 1, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K253961
- Regulatory pathway
- 510(k) premarket notification
- Product code
- JWH
- Decision code
- SESE
- Decision date
- Sep 1, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer.
- Product code
- JWH
- FDA device class
- 2
FDA decision timeline
K253961 received
Application receipt date recorded by FDA.
K253961 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code JWH
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MicroPort Total Knee SystemK263065 | Suzhou Microport Orthorecon Co., Ltd. | 510(k) clearance | Oct 29, 2026 | FDA |
GMK ExtensionK262057 | Medacta International SA | 510(k) clearance | Sep 15, 2026 | FDA |
GSPE SpacerK260063 | The General Hospital Corporation, d/b/a Massachusetts | 510(k) clearance | Sep 11, 2026 | FDA |
| Suzhou Microport Orthorecon Co., Ltd. | 510(k) clearance | Sep 10, 2026 | FDA | |
| B-One Ortho, Corp. | 510(k) clearance | Sep 8, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Just Medical Devices (Tianjin) Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Tianjin
Sources and methodology
- Original FDA record: K253961
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



